1. Editorial

   • Derek Stewart
   • Bart Pouls
   • Filipa Alves da Costa

   Editorial 13 June 2021 Pages: 439 - 440

2. Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacists

   • Olaf Rose
   • Svenja Happe
   • Susanne Erzkamp

   ESCP Best Practice 23 April 2021 Pages: 441 - 448

   

3. Prognostic factors for patients with heparin-induced thrombocytopenia: a systematic review

   • Giorgia Colarossi
   • Heike Schnöring
   • Filippo Migliorini

   Review Article 12 October 2020 Pages: 449 - 460

   

4. The role of a clinical pharmacist in spurious Penicillin allergy: a narrative review

   • Rashmeet Bhogal
   • Abid Hussain
   • Mamidipudi T. Krishna

   Review Article 13 January 2021 Pages: 461 - 475

   

5. Prophylactic antiemetic effects of dexamethasone versus 5-HT3 receptor antagonists in ear surgery: a systematic review and meta-analysis

   • Hsin-Ming Liu
   • Jin-Hua Chen
   • Cher-Ming Liou

   Review Article 13 January 2021 Pages: 476 - 485

   

6. Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis

   • Sajid Mahmood
   • Zahraa Jalal
   • Kifayat Ullah Shah

   Review Article 29 January 2021 Pages: 486 - 501

   

7. Community pharmacists’ knowledge and practice regarding malaria and its treatment in Sudan: a cross-sectional survey

   • Elkhanssa Abdelhameed Ahmed Elhag
   • Syed Azhar Syed Sulaiman

   Research Article 06 October 2020 Pages: 502 - 508

8. Colistin co-administration with other nephrotoxins: experience of teaching hospital of Latvia

   • Aleksandra Aitullina
   • Santa Purviņa
   • Angelika Krūmiņa

   Research Article 29 September 2020 Pages: 509 - 517

   

9. The role of Chinese clinical pharmacists in parenteral nutrition for children using the Screening Tool Risk on Nutrititional Status and Growth (STRONGkids)

   • Ming-Mei Zhu
   • Feng Chen
   • Jin-Chun Qiu

   Research Article 29 September 2020 Pages: 518 - 523

10. Medicines use review service in community pharmacies in Spain: REVISA project

    • Nuria García-Agua Soler
    • Eugenia Gómez-Bermúdez
    • Francisco Jódar-Sánchez

    Research Article Open access 29 September 2020 Pages: 524 - 531

11. A qualitative process evaluation of the introduction of procalcitonin testing as an antimicrobial stewardship intervention

    • F. O’Riordan
    • F. Shiely
    • A. Fleming

    Research Article 01 October 2020 Pages: 532 - 540

12. A possible effect of montelukast on neurological aging examined by the use of register data

    • Bjørn Grinde
    • Henrik Schirmer
    • Bo Engdahl

    Research Article Open access 09 October 2020 Pages: 541 - 548

13. Implementation of mouth rinsing after use of inhaled corticosteroids in Australia

    • Laura Kate Johnstone
    • Bonnie Jayne Bereznicki
    • Angus John Thompson

    Research Article 08 October 2020 Pages: 549 - 555

    

14. Patients satisfaction with free healthcare pharmaceutical services in Sierra Leone: a national cross-sectional study

    • John Alimamy Kabba
    • Abdulai Jawo Bah
    • Yu Fang

    Research Article 06 October 2020 Pages: 556 - 565

    

15. Potentially inappropriate medications involved in drug–drug interactions at hospital discharge in Croatia

    • Ivana Marinović
    • Vesna Bačić Vrca
    • Ivica Grgurević

    Research Article 01 October 2020 Pages: 566 - 576

16. The impact of decreasing potentially inappropriate medications on activities of daily living in a convalescent rehabilitation setting

    • Eiji Kose
    • Toshiyuki Hirai
    • Nobuhiro Yasuno

    Research Article 02 November 2020 Pages: 577 - 585

    

17. Validation and psychometric properties of the self-efficacy for Appropriate Medication Use Scale in elderly Chinese patients

    • Jianbo Wu
    • Zhujun Tao
    • Jie Shen

    Research Article 12 October 2020 Pages: 586 - 594

    

18. Validation of an instrument to measure adherence to type 2 diabetes management

    • Daniela Beatriz Muñoz-López
    • Verónica Reyes Pérez
    • Mónica del Carmen Preciado-Puga

    Research Article 07 October 2020 Pages: 595 - 603

19. Awareness of osteoporosis risk assessment tools and screening recommendations among community pharmacists in Malaysia

    • Jezreel Francis
    • Li Shean Toh
    • Jason S. E. Loo

    Research Article 28 January 2021 Pages: 604 - 612

    

20. Clinical, economic, and organizational impact of pharmacists’ interventions in a cognitive-behavioral unit in France

    • Teddy Novais
    • Fanny Maldonado
    • Christelle Mouchoux

    Research Article 14 October 2020 Pages: 613 - 620

21. Venous thromboembolism prophylaxis in patients undergoing knee replacements: comparison of real-world outcomes

    • Syed Shahzad Hasan
    • Wendy Sunter
    • Syed Tabish Razi Zaidi

    Research Article Open access 18 October 2020 Pages: 621 - 628

    

22. Awareness about barriers to medication adherence in cardiovascular patients and strategies used in clinical practice by Portuguese clinicians: a nationwide study

    • João Aguiar
    • Manuel Ribeiro
    • Filipa Alves da Costa

    Research Article 26 October 2020 Pages: 629 - 636

    

23. Off-label antibiotic use among paediatric in-patients: a mixed-method prospective study at a tertiary hospital in southwestern Uganda

    • Bonniface Obura
    • Paul E. Alele
    • Celestino Obua

    Research Article 18 October 2020 Pages: 637 - 644

    

24. Underutilization of gastrointestinal prophylaxis in high-risk chronic nonsteroidal anti-inflammatory drug users in Korea

    • Woo-Youn Kim
    • Suhyun Lee
    • Ju-Yeun Lee

    Research Article 04 November 2020 Pages: 645 - 653

    

25. Exploration of health professional stakeholders’ views and experiences regarding minor ailments services’ education, training and assessment

    • Mariyam Aly
    • Carl R. Schneider
    • Cherie Lucas

    Research Article 30 October 2020 Pages: 654 - 665

26. Knowledge of stroke and medication adherence among patients with recurrent stroke or transient ischemic attack in Indonesia: a multi-center, cross-sectional study

    • Karina Kumaladewi Widjaja
    • Suvatna Chulavatnatol
    • Surakit Nathisuwan

    Research Article 29 October 2020 Pages: 666 - 672

27. Discharge prescription optimization by emergency medicine pharmacists in an academic emergency department in the United States

    • Jesse Castillo
    • Matthew J. Campbell
    • Seth Podolsky

    Research Article 29 October 2020 Pages: 673 - 680

    

28. Implementation and outcome of an electronic tool for detection of paracetamol overdose in a tertiary care hospital

    • Francisco Cabrera-Diaz
    • Claudia Zaugg
    • Ali Reza Salili

    Research Article Open access 29 October 2020 Pages: 681 - 688

    

29. Impact of pharmacist-led educational interventions on asthma control and adherence: single-blind, randomised clinical trial

    • Kosisochi C. Amorha
    • Mathew J. Okonta
    • Chinwe V. Ukwe

    Research Article 02 November 2020 Pages: 689 - 697

30. Medication management during transitions from hospital to home: a focus group study with hospital and primary healthcare providers in the Netherlands

    • S. Daliri
    • C. L. Bekker
    • F. Karapinar-Çarkit

    Research Article 31 October 2020 Pages: 698 - 707

    

31. Community pharmacist’s professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists

    • Corrado Giua
    • Giovanni Paoletti
    • on behalf of SIFAC Group of Clinical Community Pharmacists (SGCP)

    Research Article 15 January 2021 Pages: 708 - 715

    

32. Burnout and the challenges facing pharmacists during COVID-19: results of a national survey

    • Karlee Johnston
    • Claire L. O’Reilly
    • Imogen Mitchell

    Research Article 13 April 2021 Pages: 716 - 725

33. Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation

    • Elisabeth Schindler
    • Ina Richling
    • Olaf Rose

    Short Research Report 06 October 2020 Pages: 726 - 730

    

34. Levels of tacrolimus after treatment for chronic hepatitis C with direct antiviral agents in solid organ transplant recipients

    • Sara Ibáñez-García
    • Eduardo Zataraín-Nicolás
    • Maria Sanjurjo Sáez

    Short Research Report 09 October 2020 Pages: 731 - 736

    

35. Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs ‘in’ rheumatoid arthritis

    • Ana Paula Monteiro Gomides
    • Cleandro Pires de Albuquerque
    • Geraldo da Rocha Castelar Pinheiro

    Short Research Report 21 October 2020 Pages: 737 - 742

36. Assessment of the complexity of drug therapy and psychosocial and behavioral aspects in people living with type 2 diabetes mellitus

    • Waleska Jaclyn Freitas Nunes de Sousa
    • Heloísa Carvalho de Torres
    • Maria Auxiliadora Parreiras Martins

    Short Research Report 30 October 2020 Pages: 743 - 747

37. Evaluation of the quality of ‘do not use’ medication abbreviation audits: a key enabler to successful implementation of audit and feedback

    • Edmond Li
    • Jennifer Marrandino
    • Sean K. Gorman

    Short Research Report 30 January 2021 Pages: 748 - 752

    

38. Practical considerations when treating chronic hepatitis E in solid organ transplant recipients

    • David K. Choi
    • Michelle T. Martin
    • Adam E. Mikolajczyk

    Commentary 09 November 2020 Pages: 753 - 755

39. Training pharmacy residents as transitions of care specialists: a United States perspective

    • Tina Joseph
    • Genevieve M. Hale
    • Cynthia Moreau

    Commentary 13 January 2021 Pages: 756 - 758

40. Shared decision making for psychiatric medication management: a summary of its uptake, barriers and facilitators

    • Deena M. Ashoorian
    • Rowan M. Davidson

    Commentary 29 January 2021 Pages: 759 - 763

41. Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases

    • Theocharis Koufakis
    • Antonis N. Pavlidis
    • Kalliopi Kotsa

    Commentary 09 March 2021 Pages: 764 - 767

    

42. A comparative study between non‑colistin based combinations for treatment of infections caused by extensive drug resistant Acinetobacter baumannii: comments

    • Roghayeh Savary
    • Maryam Taghizadeh-Ghehi
    • Samira Chaibakhsh

    Letter to the Editor 07 January 2021 Pages: 768 - 769

43. Abstracts 12th PCNE working conference ‘Partnering for better patient outcomes: challenges and opportunities 3–6 February 2021, University of Basel, Switzerland (was held online)

    ABSTRACT SET 30 April 2021 Pages: 770 - 799

44. Abstracts of the European Society of Clinical Pharmacy International Workshop on Malabsorption and Malnutrition, A Challenge for Clinical Pharmacists, 26–27 April 2021

    ABSTRACT 13 June 2021 Pages: 800 - 815